Several phosphorylation sites within the C-tail of domain of PTEN have previously been shown to reduce PTEN protein levels, stability and phosphatase activity [76,77], and although rare, epigenetic silencing of PTEN has also been identified in prostate cancer previously [75,78]. The gene discussed is PTEN; the disease is prostate carcinoma.